AxoGen Company
![](/files/companies/AxoGen.jpg)
Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.
Headquarters:
United States
Total Funding:
$515.5M
Last Funding Type:
Series G
Investors Number:
8
Technology:
Other
Estimated Revenue:
$10M to $50M
Industry:
Genomic and Epigenominc Instabillity